1. Home
  2. INTT vs ADVM Comparison

INTT vs ADVM Comparison

Compare INTT & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • ADVM
  • Stock Information
  • Founded
  • INTT 1981
  • ADVM 2006
  • Country
  • INTT United States
  • ADVM United States
  • Employees
  • INTT N/A
  • ADVM N/A
  • Industry
  • INTT Semiconductors
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INTT Technology
  • ADVM Health Care
  • Exchange
  • INTT Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • INTT 91.8M
  • ADVM 98.0M
  • IPO Year
  • INTT 1997
  • ADVM 2014
  • Fundamental
  • Price
  • INTT $7.87
  • ADVM $4.50
  • Analyst Decision
  • INTT Strong Buy
  • ADVM Strong Buy
  • Analyst Count
  • INTT 2
  • ADVM 6
  • Target Price
  • INTT $16.00
  • ADVM $27.83
  • AVG Volume (30 Days)
  • INTT 50.0K
  • ADVM 189.1K
  • Earning Date
  • INTT 03-07-2025
  • ADVM 03-21-2025
  • Dividend Yield
  • INTT N/A
  • ADVM N/A
  • EPS Growth
  • INTT N/A
  • ADVM N/A
  • EPS
  • INTT 0.24
  • ADVM N/A
  • Revenue
  • INTT $130,690,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • INTT $7.28
  • ADVM N/A
  • Revenue Next Year
  • INTT $5.39
  • ADVM $1,162.55
  • P/E Ratio
  • INTT $33.08
  • ADVM N/A
  • Revenue Growth
  • INTT 5.99
  • ADVM N/A
  • 52 Week Low
  • INTT $6.28
  • ADVM $3.52
  • 52 Week High
  • INTT $14.35
  • ADVM $18.50
  • Technical
  • Relative Strength Index (RSI)
  • INTT 45.05
  • ADVM 51.62
  • Support Level
  • INTT $7.73
  • ADVM $4.20
  • Resistance Level
  • INTT $8.21
  • ADVM $4.91
  • Average True Range (ATR)
  • INTT 0.46
  • ADVM 0.49
  • MACD
  • INTT -0.03
  • ADVM 0.06
  • Stochastic Oscillator
  • INTT 29.71
  • ADVM 60.49

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: